BCRX Historical PE Ratio image   This BCRX PE ratio history page last updated 5/9/2022
BCRX Historical PE Ratio Chart
Data adjusted for BCRX split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/5/2022
9.78-0.40-1.60NA
Q4 2021
2/23/2022
16.70-0.40-1.60NA
Q3 2021
11/3/2021
12.40-0.33-1.32NA
Q2 2021
8/5/2021
17.65-0.24-0.96NA
Q1 2021
5/6/2021
12.92-0.36-1.44NA
Q4 2020
2/25/2021
10.47-0.34-1.36NA
Q3 2020
11/5/2020
4.24-0.26-1.04NA
Q2 2020
8/6/2020
4.00-0.24-0.96NA
Q1 2020
5/6/2020
3.86-0.24-0.96NA
Q4 2019
3/5/2020
3.83-0.02-0.08NA
Q3 2019
11/6/2019
2.01-0.34-1.36NA
Q2 2019
8/6/2019
2.97-0.34-1.36NA
Q1 2019
5/8/2019
7.81-0.28-1.12NA
Q4 2018
3/4/2019
8.79-0.25-1.00NA
Q3 2018
11/6/2018
7.77-0.28-1.12NA
Q2 2018
8/7/2018
6.06-0.19-0.76NA
Q1 2018
5/8/2018
5.03-0.26-1.04NA
Q4 2017
2/27/2018
4.83-0.20-0.80NA
Q3 2017
11/7/2017
4.70-0.18-0.72NA
Q2 2017
8/7/2017
4.42-0.21-0.84NA
Q1 2017
5/4/2017
5.79-0.19-0.76NA
Q4 2016
2/27/2017
5.51-0.06-0.24NA
Q3 2016
11/7/2016
4.49-0.16-0.64NA
Q2 2016
8/4/2016
4.00-0.22-0.88NA
Q1 2016
5/5/2016
2.73-0.31-1.24NA
Q4 2015
2/23/2016
1.90-0.25-1.00NA
Q3 2015
11/5/2015
9.57-0.20-0.80NA
Q2 2015
8/7/2015
10.900.060.2445.4
Q1 2015
5/8/2015
10.09-0.21-0.84NA
Q4 2014
2/18/2015
10.11-0.16-0.64NA
Q3 2014
11/6/2014
10.32-0.12-0.48NA
Q2 2014
8/5/2014
13.34-0.23-0.92NA
Q1 2014
5/8/2014
7.37-0.17-0.68NA
Q4 2013
2/26/2014
11.86-0.09-0.36NA
Q3 2013
11/5/2013
5.41-0.14-0.56NA
Q2 2013
8/8/2013
5.45-0.23-0.92NA
Q1 2013
5/7/2013
1.87-0.09-0.36NA
Q4 2012
2/19/2013
1.40-0.22-0.88NA
Q3 2012
11/7/2012
2.45-0.19-0.76NA
Q2 2012
8/2/2012
4.30-0.25-1.00NA
BCRX PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/5/2022
9.78-0.40-1.37NA
Q4 2021
2/23/2022
16.70-0.40-1.33NA
Q3 2021
11/3/2021
12.40-0.33-1.27NA
Q2 2021
8/5/2021
17.65-0.24-1.20NA
Q1 2021
5/6/2021
12.92-0.36-1.20NA
Q4 2020
2/25/2021
10.47-0.34-1.08NA
Q3 2020
11/5/2020
4.24-0.26-0.76NA
Q2 2020
8/6/2020
4.00-0.24-0.84NA
Q1 2020
5/6/2020
3.86-0.24-0.94NA
Q4 2019
3/5/2020
3.83-0.02-0.98NA
Q3 2019
11/6/2019
2.01-0.34-1.21NA
Q2 2019
8/6/2019
2.97-0.34-1.15NA
Q1 2019
5/8/2019
7.81-0.28-1.00NA
Q4 2018
3/4/2019
8.79-0.25-0.98NA
Q3 2018
11/6/2018
7.77-0.28-0.93NA
Q2 2018
8/7/2018
6.06-0.19-0.83NA
Q1 2018
5/8/2018
5.03-0.26-0.85NA
Q4 2017
2/27/2018
4.83-0.20-0.78NA
Q3 2017
11/7/2017
4.70-0.18-0.64NA
Q2 2017
8/7/2017
4.42-0.21-0.62NA
Q1 2017
5/4/2017
5.79-0.19-0.63NA
Q4 2016
2/27/2017
5.51-0.06-0.75NA
Q3 2016
11/7/2016
4.49-0.16-0.94NA
Q2 2016
8/4/2016
4.00-0.22-0.98NA
Q1 2016
5/5/2016
2.73-0.31-0.70NA
Q4 2015
2/23/2016
1.90-0.25-0.60NA
Q3 2015
11/5/2015
9.57-0.20-0.51NA
Q2 2015
8/7/2015
10.900.06-0.43NA
Q1 2015
5/8/2015
10.09-0.21-0.72NA
Q4 2014
2/18/2015
10.11-0.16-0.68NA
Q3 2014
11/6/2014
10.32-0.12-0.61NA
Q2 2014
8/5/2014
13.34-0.23-0.63NA
Q1 2014
5/8/2014
7.37-0.17-0.63NA
Q4 2013
2/26/2014
11.86-0.09-0.55NA
Q3 2013
11/5/2013
5.41-0.14-0.68NA
Q2 2013
8/8/2013
5.45-0.23-0.73NA
Q1 2013
5/7/2013
1.87-0.09-0.75NA
Q4 2012
2/19/2013
1.40-0.22NANA
Q3 2012
11/7/2012
2.45-0.19NANA
Q2 2012
8/2/2012
4.30-0.25NANA
Quotes delayed 20 minutes

Email EnvelopeFree BCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocryst Pharmaceuticals (BCRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BDSI PE Ratio History
BDSX PE Ratio History
BDTX PE Ratio History
BDX PE Ratio History
BEAM PE Ratio History
BFLY PE Ratio History
BHG PE Ratio History
BIIB PE Ratio History
BIO PE Ratio History
BIOC PE Ratio History
How should the BCRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Biocryst Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BCRX Historical PE Ratio page.

What is the average historical PE for BCRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BCRX historical PE ratio using the annualized quarterly earnings method works out to 45.4.

What is the average historical PE for BCRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BCRX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the BCRX Historical PE Ratio information for Biocryst Pharmaceuticals' stock. The average BCRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 45.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BCRX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BCRX historical PE result, against the recent PE: when this page was posted on 5/6/2022, the most recent closing price for BCRX had been 9.09, and the most recent quarterly earnings result, annualized, was 0.24. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent BCRX PE on 5/6/2022 based on annualized quarterly EPS was 37.9. Based on BCRX's history, that recent PE is low relative to the historical average, with the recent PE 16.5% lower than the historical average PE across our data set for Biocryst Pharmaceuticals.

For self directed investors doing their due diligence on BCRX or any other given stock, valuation analysis for BCRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Biocryst Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BCRX. Thanks for visiting, and the next time you need to research BCRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: NXGN Insider Buying, Institutional Holders of ESCR, RMGN shares outstanding history.

 

BCRX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.